The UK's national research agency, UKRI, is committing up to £30 million (~$105 million) to trial nine innovative technologies aimed at slashing dementia diagnosis wait times — which currently can stretch beyond a year. The initiative will test tools ranging from faster MRI brain scans and blood tests to a 15-minute remote cognitive assessment, all within the National Health Service.

Only technologies that prove their worth during NHS trials will receive additional funding, under what UKRI calls a "fail-fast" approach — designed to weed out ineffective solutions quickly and accelerate adoption of what actually works. An AI tool to predict disease progression and a home sensor system to enable earlier clinical intervention are also among the projects in the pipeline.

By the Numbers:

• £30 million (~$105 million) in funding committed
• 92% of patients to be diagnosed within 18 weeks of referral (up from ~60% today)
• MRI scan time targeted to drop from ~20 minutes to ~7 minutes
• 72,000+ people in the UK died from dementia (including Alzheimer's) last year
• Dementia accounts for nearly 1 in 8 deaths in the UK

Why it matters: Dementia is the UK's leading cause of death, yet diagnosis remains slow and inconsistent. Faster, more accurate diagnosis means earlier intervention, better patient outcomes, and reduced strain on an already stretched NHS.